相关实验视频
Updated: Jun 14, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.0K
肌肉内免疫接种用脂质体多位化学蛋白诱导强大的细胞免疫反应,对脏莱什曼病
Maria Agallou1, Maritsa Margaroni1, Evdokia Karagouni1
1Immunology of Infection Group, Department of Microbiology, Hellenic Pasteur Institute, 115 21 Athens, Greece.
Vaccines
|August 26, 2023
概括
一种新型的候选疫苗LiChimera被封装在cationic脂质体中,通过增强1型细胞免疫力和记忆T细胞,显著地保护了对内脏莱什曼病的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 控制像Leishmania这样的细胞内寄生虫依赖于1型细胞免疫反应.
- 内脏莱什曼病仍然是一个重大的全球健康挑战,需要有效的疫苗策略.
研究的目的:
- 针对实验性内脏莱什曼病,研究封装在阴性脂质体中的多皮托普化学蛋白 (LiChimera) 的保护功效.
主要方法:
- LiChimera被封装成阴阳性脂质体.
- 脂质体配方的有效性在实验性内脏莱什曼病模型中进行了测试.
- 分析了免疫反应,包括T细胞分化和细胞因子的产生.
主要成果:
- 脂质体LiChimera显著降低了脏和肝脏中的Leishmania寄生虫负载.
- 保护与持久的细胞免疫有关,包括多功能记忆CD4+TH1和CD8+T细胞.
- 被保护的小鼠表现出IFN-γ和IL-10共产CD4+T细胞的减少种群.
结论:
- 含有LiChimera的阴阳性脂质体代表了对内脏莱什曼病的有希望的疫苗候选人.
- 疫苗诱导了强大的,持久的细胞免疫反应,这对于控制寄生虫至关重要.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

